The Valens Company ( TSX:VLNS, OTCQX:VLNCF ) Inc. has announced an exclusive partnership with Epsilon Healthcare Limited, a diversified global healthcare and pharmaceuticals company, for access to Epsilon's Good Manufacturing Practices (GMP) facility in Australia for manufacturing products. In a statement, Valens said the partnership furthers its international expansion to GMP's markets in Latin America, Europe, UK, and the Asia-Pacific regions. Products will be distributed through Valens' Australian distribution partner, Cannvalate PTY Ltd, and to date, will be the largest quantity of products provided to Cannvalate for distribution.